ODU Digital Commonsmetadata only
Use of Tezepelumab for Chronic Rhinosinusitis with Nasal Polyps by Eosinophilic Endotype: WAYPOINT Post-Hoc Analysis
asthma—complications, biological products—therapeutic use, chronic rhinosinusitis, eosinophilia, monoclonal antibodies—therapeutic use, nasal polyps, precision medicine, respiratory allergy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 1001623
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.